Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
International Archives of Allergy and Immunology
|
December 1, 1996
Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis
W H Nikolaizik, R Crameri, K Blaser, et al.
International Archives of Allergy and Immunology
|
September 30, 1998
Determinants and mechanisms of human immune responses to bee venom phospholipase A2
K Blaser, J Carballido, A Faith, et al.
Mycoses
|
August 26, 1998
[Molecular aspects and diagnostic value of fungal allergens]
R Crameri, S Hemmann, C Mayer, et al.
International Immunology
|
September 2, 1998
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
R Crameri, S Hemmann, C Ismail, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 28, 1998
Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus
S Hemmann, C Ismail, K Blaser, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 1994
Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology
M Moser, R Crameri, E Brust, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 1, 1997
Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2
U Müller, M Fricker, D Wymann, et al.
International Archives of Allergy and Immunology
|
May 1, 1997
Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus
C Mayer, S Hemmann, A Faith, et al.
Allergy
|
February 15, 2007
Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines
R Crameri, S Flückiger, I Daigle, et al.
The Journal of Allergy and Clinical Immunology
|
September 14, 1999
Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization
S Hemmann, G Menz, C Ismail, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
International Archives of Allergy and Immunology
|
December 1, 1996
Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis
W H Nikolaizik, R Crameri, K Blaser, et al.
International Archives of Allergy and Immunology
|
September 30, 1998
Determinants and mechanisms of human immune responses to bee venom phospholipase A2
K Blaser, J Carballido, A Faith, et al.
Mycoses
|
August 26, 1998
[Molecular aspects and diagnostic value of fungal allergens]
R Crameri, S Hemmann, C Mayer, et al.
International Immunology
|
September 2, 1998
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
R Crameri, S Hemmann, C Ismail, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 28, 1998
Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus
S Hemmann, C Ismail, K Blaser, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 1994
Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology
M Moser, R Crameri, E Brust, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 1, 1997
Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2
U Müller, M Fricker, D Wymann, et al.
International Archives of Allergy and Immunology
|
May 1, 1997
Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus
C Mayer, S Hemmann, A Faith, et al.
Allergy
|
February 15, 2007
Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines
R Crameri, S Flückiger, I Daigle, et al.
The Journal of Allergy and Clinical Immunology
|
September 14, 1999
Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization
S Hemmann, G Menz, C Ismail, et al.
Page
of 14